Clinical trials are undergoing a period of change. Innovative uses of artificial intelligence (AI) are unlocking better insights. Regulators are backing risk-based approaches and a focus on the issues that matter. In this period of evolution, sponsors and CROs need to choose the right solutions—and the right partners—to help keep research rising.
